Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): Final 3-year results from a multicentre, randomised controlled trial
Gregg W. Stone, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce R. Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, Bernard J. Gersh, Stuart J. Pocock, George Dangas, S. Chiu Wong, Martin Fahy, Helen Parise, Roxana Mehran
Research output: Contribution to journal › Article › peer-review
396Scopus
citations
Fingerprint
Dive into the research topics of 'Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): Final 3-year results from a multicentre, randomised controlled trial'. Together they form a unique fingerprint.